Corrigendum to "Clinical and cognitive outcomes in Ocrelizumab-treated MS patients: Insights into the wearing-off phenomenon" [Multiple Sclerosis and Related Disorders, Volume 103, November 2025, 106689].
Seferoğlu M, Tunç A, Sıvacı A Ö, Karakaş Z, Öncel S
Mult Scler Relat Disord. 2026 Jun; 110:107191. PMID: 42134895.Abstract
